FT. LAUDERDALE, Fla., Oct. 23, 2008 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2008 financial results after market close on Thursday, November 6, 2008. Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the third quarter results starting at 4:30 p.m. EST on the same day. The call will be concurrently webcast.
To listen to the conference call please dial 800-811-8830 for domestic callers and 913-312-0386 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the Investor Relations section of MAKO's website at www.makosurgical.com. Following the call, a webcast replay will be available on MAKO's website, and an audio replay will also be available by calling 888-203-1112 (719-457-0820 for international callers) and entering the passcode 3344855. Both the audio and webcast replays will be available through November 20, 2008.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) is a surgeon-interactive tactile platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the precise and consistently reproducible insertion and alignment of resurfacing implants through a minimal incision. This FDA-cleared TGS allows surgeons to provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 200 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, haptics, robotics and implants. Additional information can be found at www.makosurgical.com.